A citation-based method for searching scientific literature

Margaret T Behme, John Dupré, Thomas J McDonald. BMC Endocr Disord 2003
Times Cited: 53

M Gutniak, C Orskov, J J Holst, B Ahrén, S Efendic. N Engl J Med 1992
Times Cited: 788

List of shared articles

Times cited

Exendin-4 normalized postcibal glycemic excursions in type 1 diabetes.
John Dupré, Margaret T Behme, Thomas J McDonald. J Clin Endocrinol Metab 2004

[Adjunctive therapies to glycaemic control of type 1 diabetes mellitus].
Mônica de A Lima Gabbay. Arq Bras Endocrinol Metabol 2008

Insulin deficiency, but not resistance, exaggerates cognitive deficits in transgenic mice expressing human amyloid and tau proteins. Reversal by Exendin-4 treatment.
Matthew R King, Nicholas J Anderson, Mihaela Deciu, Lucie S Guernsey, Morgan Cundiff, Shohreh Hajizadeh, Corinne G Jolivalt. J Neurosci Res 2020

New potential adjuncts to treatment of children with type 1 diabetes mellitus.
Vandana S Raman, Rubina A Heptulla. Pediatr Res 2009

Glucagon-like peptide 1(GLP-1) in biology and pathology.
Juris J Meier, Michael A Nauck. Diabetes Metab Res Rev 2005

GLP-1 signals via ERK in peripheral nerve and prevents nerve dysfunction in diabetic mice.
C G Jolivalt, M Fineman, C F Deacon, R D Carr, N A Calcutt. Diabetes Obes Metab 2011

Is exenatide a useful addition to diabetes therapy?
Nasser E Mikhail. Endocr Pract 2006

Liraglutide for treating type 1 diabetes.
Thomas Fremming Dejgaard, Christian Seerup Frandsen, Jens Juul Holst, Sten Madsbad. Expert Opin Biol Ther 2016

Glucagon-like peptide: the time is near.
Alvin Huang, Philip Raskin. Basic Clin Pharmacol Toxicol 2004